Revvity (RVTY) SVP Vohra Tajinder S Sells $1M of Stock

Revvity, Inc. (NYSE: RVTY) Senior Vice President, Global Operations Vohra Tajinder S sold 7,330 shares of the company on September 16, 2026. According to a Form 4 filing with the SEC, the transaction was carried out at a price of $140.88 per share, for a total value of $1,032,650.40.

RVTY Revvity, Inc.

$152.64 ▲ +55.83% year to date

1M 3M YTD

Daily close · Oct 16, 2026

Inside Vohra Tajinder S's Revvity Trade

The planned sale was executed under a pre-arranged Rule 10b5-1 trading plan. On the transaction date, Revvity stock closed at $145.73.

Other Institutional Activity in Revvity

Other large funds have adjusted their stakes in Revvity recently. Jupiter Topco LLC held 8,637,614 shares worth about $1.32 billion after a massive change. Edgepoint Investment Group Inc. reduced its holdings by 256,097 shares, ending with 8,544,479 shares valued at roughly $1.30 billion. Victory Capital Management Inc. grew its holdings by 273,190 shares, ending with 3,645,905 shares worth about $556.5 million.

Revvity, Inc. Stock Down 0.9%

Revvity shares recently traded around $153.35, sitting well above their 200-day moving average of $109.12. The stock has a market capitalization of roughly $17.03 billion and a P/E ratio of 73.03.

Recent Earnings

Revvity reported trailing-twelve-month revenue of $2.91 billion and earnings of $2.09 per share. The company posted a net profit margin of 8.2% and a return on equity of 3.2%. Revvity is scheduled to release its next quarterly financial results on November 3, 2026.

Dividend

Revvity pays an annual dividend rate of $0.28 per share, giving it a dividend yield of 0.18%. The company's dividend payout ratio stands at 13.4%.

Insider Buying and Selling at Revvity, Inc.

Insider transactions at Revvity include several sales over the past year. Director Michelle Mcmurry-Heath sold 600 shares on February 23, 2026, at $97.26 per share for a total of $58,356. Officer Miriame Victor sold 1,862 shares on February 24, 2026, at $97.13 per share totaling $180,856. Officer Anita Gonzales sold 80 shares on April 20, 2026, at $92.80 per share, and later sold 85 shares on July 20, 2026, at $109.48 per share.

Analysts Set New Price Targets

Analyst coverage includes several recent rating updates. Evercore ISI Group maintained an Outperform rating while raising its price target to $126 on August 5, 2026. RBC Capital initiated coverage with a Sector Perform rating and a $135 target on September 1, 2026. Keybanc maintained an Overweight rating and lifted its target to $165 on September 4, 2026. TD Cowen maintained a Buy rating and raised its target to $175 on October 13, 2026. The stock currently holds a consensus buy recommendation with a mean price target of $147.53.

About Revvity

Revvity provides health sciences solutions, technologies, and services. The Waltham, Massachusetts-based company develops diagnostic tools, reagents, and imaging software used for early disease detection and research applications.

Bottom Line

Investors will look toward Revvity's upcoming earnings report on November 3, 2026, for further updates on financial performance. Insider transactions under pre-arranged plans provide regular insight into executive stock management.